Reuters logo
BRIEF-Inovio Pharmaceuticals reports positive results from phase 1 trial of zika virus vaccine
2017年10月5日 / 上午11点11分 / 12 天前

BRIEF-Inovio Pharmaceuticals reports positive results from phase 1 trial of zika virus vaccine

Oct 5 (Reuters) - Inovio Pharmaceuticals Inc:

* Inovio Pharmaceuticals Inc ‍reported on positive safety and immune response results from phase 1 trial of a vaccine against zika virus​

* Inovio Pharmaceuticals - ‍phase 1 trial of co’s dna-based zika vaccine (gls-5700) induced high levels of binding antibodies in 100% of participants​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below